MRSA Barbara Kilian, MD St.Luke’s Roosevelt Academic Associate Program Fall 2005.

Slides:



Advertisements
Similar presentations
Erm C Methylase erm I Regulation of erm Methylase Constitutive Inducible Macrolides Methylase.
Advertisements

MRSA Community Acquired Methicillin Resistant Staphylococcus Aureus
Population- based Surveillance of Reportable Diseases in Nursing Home Facilities in Nebraska Manjiri Joshi, MPH + Alison Keyser Metobo, MPH + + Epidemiology.
MRSA: Epidemiology & Treatment. MRSA: Epidemiology & Treatment: Points of this Talk - MRSA is primarily healthcare-associated - Community-acquired MRSA.
Schools in Several States Report Staph Infections, and Deaths Raise the Alarm By IAN URBINA, NY Times Published: October 19, 2007
Invasive Group A Strep Infections Associated With Bath Salts Injection Patty Carson, BA, SM (ASCP) 1,2, Sara Robinson, MPH 1, Stephen Sears, MD, MPH 1.
Commons.wikimedia.org Introduction  Staphylococcus aureus (SA) is a gram- positive cocci bacterium. The Methicillin- resistant SA (MRSA) is a strain resistant.
Methicillin-Resistant Staphylococcus aureus (MRSA) Information provided by the Pickaway County General Health District.
MRSA.
Methicillin Resistant Staphylococcus aureus (MRSA) in the Community: Epidemiology and Management Rachel Gorwitz, MD, MPH Division of Healthcare Quality.
The War Against MRSA By Cynthia Zips, M, SM(ASCP), CIC October 25, 2013 MPH 500- Fundamentals of Public Health – Section 01- Fall A 2013 Instructor: Madeline.
Overview  What it is  History  Signs and symptoms  Rick Factors  Treatment  Prevention.
MRSA Methicillin Resistant Staphylococcus Aureus
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
The Ugly face of MRSA (Methicillin Resistant Staphylococcus aureus) MRSA is a staph aureus infection that has become resistant to the class of antibiotics,
Outpatient management of skin and soft tissue infections, specifically for community-associated MRSA Patient presents with signs/ symptoms of skin infection:
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Live, Learn, Work and Play
A SECOND LOOK AT HOW TO COMBAT THIS THREAT JOHN WOODCOX RN CRRN.
Information on Staphlococcus aureus and Resistant Staphlococcus aureus (MRSA) Prepared by: Kathryn Billings.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Methicillin-resistant Staphylococcus Aureus by Torie Stratton, Jordan Scott, and Megan Pazzelli.
©2008, Promega Corporation. All rights reserved. Emerging Pathogens Community-Associated Methicillin- Resistant Staphylococcus aureus.
Methicillin-Resistant Staphylococcus aureus Infections in California Hospital Patients, 1999 – 2006 Mary Tran, PhD, MPH Niya Fong, BS Microbiology California.
MRSA Definition Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA is by definition.
Methicillin Resistant Staphylococcus aureus (MRSA): Proposed Revision of ICD-9 Codes Rachel Gorwitz, MD, MPH Division of Healthcare Quality Promotion Centers.
Community- Associated MRSA Maha Assi, MD, MPH. MRSA Hits the Media October 16, 2007 October 16, 2007 Lead story on MRSA Lead story on MRSA “superbug killing.
Methicillin-Resistant Staphylococcus aureus (MRSA)
Emerging and Re-emerging Diseases. Which killed more people: WWI ( ) or the Influenza Epidemic of 1918? World War I (1914 – 1918) death toll:
Clinical Microbiology ( MLCM- 201) Prof. Dr. Ebtisam.F. El Ghazzawi. Medical Research Institute (MRI) Alexandria University.
Soft Tissue Infections
MRSA in Corrections Danae Bixler, MD, MPH
MRSA and VRE in a Rural Community Hospital Graduation Project 2008 Mehvish Ally.
Staphylococcal Bacteremia and Endocarditis: Epidemiological Considerations March 6, 2006 John Edwards, Jr., M.D Professor of Medicine UCLA School of Medicine.
Clindamycin induction test in treating patients infected with methicilin resistant Staphylococcus aureus Presented by Iyad Kaddora.
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
Prevalence of Methicillin-resistant Staphylococcus aureus in El Oro Province, Ecuador Student Researchers: Christopher A. Monte, Beatrice R. Soderholm.
MRSA in Correctional Facilities Michael Kelley, M.D., M.P.H. Director of Preventive Medicine Texas Department of Criminal Justice.
The Super Bug? Alexander L. Brzezny, MD, MPH Health Officer Grant County Health District September 4 th, 2007.
Mason Hughes, Arek Hively and Jacob Mazzei. Type of Disease Methicillin-resistant Staphylococcus Aureus Can also be known as MRSA.
MRSA in Our Community Tony Chang, MD Primary Care Case Conference August 2, 2006.
Prevalence of Methicillin-Resistant Staphylococcus aureus in Loja Province, Ecuador Student Researcher: Lauren Lamers, Faculty Researcher: Daniel Herman,
Antibacterial Drugs and the Risk of Community-Associated Methicillin-Resistant Staphylococcus aureus in Children Schneider-Lindner V, Quach C, Hanley JA,
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
Community-Associated Methicillin-Resistant Staphylococcus aureus Ruth Lynfield, M.D. Minnesota Department of Health.
Prevalence of Methicillin-Resistant Staphylococcus aureus in 4A and 5A High Schools in Texas UIL Region IV Fall 2004 By Carolina Espinoza Public Health.
Understanding Methicillin-Resistant Staphylococcus aureus
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
MRSA (Methicillin-resistant Staphylococcus Aureus) By: Matt Steer, Dylan Scott, Jordan Wolford, Kaylla Vaughn.
Methicillin Resistant Staphylococcus Aureus
MRSA (Methacillin- Resistant Staph Aureus) Deborah Moore, MS, APRN, BC VT PHS Regional Administrator.
U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.
Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital.
Retrospective study of community-acquired methicillin- resistant Staphylococcus aureus (CA-MRSA) infections in a west Texas community, 2004 American Public.
Abscess Management in a Post CA-MRSA era Erin Marra MD Simran Vahali MD 2016.
Staph Infections. What is staph? Staphylococcus aureus, often referred to simply as “staph,” are bacteria commonly carried on the skin or in the nose.
MRSA.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
Carriage Rates of Methicillin-Resistant Staphylococcus aureus (MRSA) Among College Students Ryan Kitzinger, Leigh Nelson, Chad Sethman, Ph.D. ABSTRACT.
By: Wajidah Abdul-Khabir PGY-2
Use of antibiotics.
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Are abx always necessary?
MRSA=Methicillin resistant Staphylococcus aureus
Presentation transcript:

MRSA Barbara Kilian, MD St.Luke’s Roosevelt Academic Associate Program Fall 2005

Study Design  Prospective  Observational

The point  Quantitatively and qualitatively characterize the presentation of skin infections caused by MRSA  CA-MRSA  HA-MRSA

Staphylococcus Aureus  Normal flora  Infections Skin/Soft Tissue Pneumonia Scalded Skin

Staph Aureus Gram stain “Gram positive cocci in clusters”

Infections Pneumonia

Infections cellulitis

Infections Boils

Infections

Skin Anatomy

Incision and Drainage

Why bother with the study?  MRSA is more prevelant  It doesn’t respond to normal ABX  Few studies done aren’t great

Methicillin-Resistant Staphylococcus aureus Disease in Three Communities Scott K. Fridkin, M.D., Jeffrey C. Hageman, M.H.S., Melissa Morrison, M.P.H., Laurie Thomson Sanza, R.N., Kathryn Como-Sabetti, M.P.H., John A. Jernigan, M.D., Kathleen Harriman, Ph.D., Lee H. Harrison, M.D., Ruth Lynfield, M.D., Monica M. Farley, M.D., for the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network  Background Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. The national burden and clinical effect of this novel presentation of MRSA disease are unclear.  Methods We evaluated MRSA infections in patients identified from population-based surveillance in Baltimore and Atlanta and from hospital-laboratory–based sentinel surveillance of 12 hospitals in Minnesota. Information was obtained by interviewing patients and by reviewing their medical records. Infections were classified as community-acquired MRSA disease if no established risk factors were identified.  Results From 2001 through 2002, 1647 cases of community-acquired MRSA infection were reported, representing between 8 and 20 percent of all MRSA isolates. The annual disease incidence varied according to site (25.7 cases per 100,000 population in Atlanta vs per 100,000 in Baltimore) and was significantly higher among persons less than two years old than among those who were two years of age or older (relative risk, 1.51; 95 percent confidence interval, 1.19 to 1.92) and among blacks than among whites in Atlanta (age-adjusted relative risk, 2.74; 95 percent confidence interval, 2.44 to 3.07). Six percent of cases were invasive, and 77 percent involved skin and soft tissue. The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. Among patients with skin or soft- tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. Overall, 23 percent of patients were hospitalized for the MRSA infection.  Conclusions Community-associated MRSA infections are now a common and serious problem. These infections usually involve the skin, especially among children, and hospitalization is common.

Our Study  Incision & drainage of ALL abscesses  Culture ALL of these  Follow up  Screen for ‘risk factors’

Risk Factors for HA-MRSA  Hospitalized w/in last year  Surgery w/in last year  Dialysis w/in last year  Resided in long-term care facility w/in last year  Permanent device  Positive culture in past for MRSA  ABX >3 times w/in past year  Close proximity to person with abscess/skin inf.  Has every had an abscess  DM  Injection drug use

For CA-MRSA  Sports activity  Crowded living conditions  Recurrent skin disease  “Spider” bite or other insect bite

I still don’t get what the fuss is about….  Resistant to normal therapy  Recurrance  Exposure of others.  Leads to further resistance.